Khiron Life Sciences Corp. (TSXV: KHRN), (OTCQB: KHRNF), an integrated medical cannabis company with its core operations in Colombia, has signed the definitive agreement for the acquisition of the Latin American Institute of Neurology and the Nervous System ("ILANS") previously announced on August 7, 2018.
Read more
Khiron Life Sciences Announces Launch of Khiron Clinics With the Signing of the Definitive Agreement to Acquire ILANS
